critical COVID-19 patient
[용어속성] Term
Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study
Research
[키워드] 95% CI
adjusted hazard ratio
affected
age
Analysis
ARDS
association
chest CT scan
Cohort
COVID-19
critical COVID-19 patient
Critically ill patient
critically ill patients
delay in intubation
Early intubation
evaluated
Follow-up
greater
hospital
hospital discharge
Impact
IMV
in-hospital mortality
increase in
Intubated
intubation
Invasive mechanical ventilation
lobe
male
material
mean difference
median
Mortality
Patient
Prospective
prospective cohort study
pulmonary sequelae
receiving
required
respiratory management
Respiratory Support
Result
risk
significant increase
supplementary material
survival
TSS
with COVID-19
[DOI] 10.1186/s13054-021-03882-1 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-021-03882-1 PMC 바로가기 [Article Type] Research
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes
COVID-19 및 패혈성 증후군의 내피병증에서의 독특한 바이오마커 특징
Comparative Study
[키워드] Activation
ADAMTS
adhesion
analyzed
Biomarker
Biomarkers
both groups
circulating
clinical disease
collected
complement
Complement activation
contributing to
Control
COVID-19
COVID-19 disease
COVID-19 disease severity
COVID-19 group
COVID-19 patient
COVID-19 patients
COVID-19 phenotype
COVID-19 pneumonia
Critical
critical COVID-19 patient
critical COVID-19 patients
Critically ill
critically ill COVID-19 patients
Culture
disease
disease severity
dsDNA
dysregulation
e parameters
endothelial
Endothelial cell
endothelial cells
endothelial damage
endotheliopathy
except for
Factor
fibrinolysis
fibrinolytic
healthy donor
healthy donors
help
heparan sulfate
Hospitalization
ICU
in both groups
increased expression
information
intensive care
life-threatening
mitigate
moderate
morbidity and mortality
motif
NETs
neutrophil
Neutrophil extracellular trap
Neutrophil extracellular traps
parameter
pathophysiology
Patient
Phenotypes
plasma samples
Pneumonia
progression
receptor
Result
Sepsis
sepsis syndrome
septic
Septic shock
severity of COVID-19
significantly
significantly higher
significantly lower
SIRS
Stage
Stress
sulfate
syndrome
systemic inflammatory response
systemic inflammatory response syndrome
therapeutic strategy
thrombomodulin
TNF
volunteers
von Willebrand factor
vWF
was related
with COVID-19
[DOI] 10.1097/SHK.0000000000001823 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1097/SHK.0000000000001823 PMC 바로가기 [Article Type] Comparative Study
COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management
Review
[키워드] addition
Anti-inflammatory drugs
anticoagulant therapy
antiplatelet
Antithrombotic
blood flow
caused
clinical
Clinical prognosis
clinical trial
complex interaction
controls
Coronavirus disease 2019
COVID-19
COVID-19 patients
critical COVID-19 patient
disease severity
Diseases
drug
drugs
effective
element
Endothelial dysfunction
Factor
global pandemic
Hospitalized
hypercoagulability
IMPROVE
occur
Occurrence
outlined
pathological
pathological mechanism
pathophysiological mechanism
pathophysiology
Prognosis
risk factor
SARS-COV-2 infection
therapy
thrombosis
thrombotic
thrombotic event
Treatment
treatments for COVID-19
Venous Thromboembolism
Venous thrombosis
VTE
[DOI] 10.3390/jpm11121328 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jpm11121328 PMC 바로가기 [Article Type] Review
Outcomes of tocilizumab therapy in severe or critical COVID-19 patients: A retrospective cohort, single-centre study
중증 또는 중증 COVID-19 환자에서 토실리주맙 요법의 결과: 후향적 코호트, 단일 센터 연구
Article
[키워드] adjusted hazard ratio
antibody
C-reactive protein
Clinical improvement
clinically
COVID-19
Critical
critical COVID-19 patient
critical COVID-19 patients
D-dimer
Effectiveness
ferritin level
Follow-up
greater
group
hospital
in-hospital mortality
in-hospital mortality rate
intravenous tocilizumab
Kuwait
lactate dehydrogenase
likelihood
median
Mortality
occurred
Patient
patients
procalcitonin
receptor
reduced risk
regression analysis
retrospective cohort
retrospective cohort study
Secondary infection
severe coronavirus disease
significantly
significantly lower
Standard of care
Standard-of-care
statistical significance
survival
TCZ
Tocilizumab
tocilizumab therapy
Treatment
[DOI] 10.1111/tmi.13685 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/tmi.13685 PMC 바로가기 [Article Type] Article
Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
Article
[키워드] Clostridioides difficile
Administered
Analysis
Antibiotic therapy
Antibiotics
caused
change
Clostridioide
Control
control group
controls
COVID-19
COVID-19 group
COVID-19 pandemic
critical COVID-19 patient
detection rate
hospital
hygiene
ICU
increase in
intensive care
molecular typing of VRE
oral vancomycin prophylaxis
Patient
patients
precautions
Prevalence
Prophylaxis
reduced
Retrospective study
risk
risk of infection
Severe COVID-19 pneumonia
significant increase
Spread
strict hygiene measure
vancomycin-resistant enterococci
[DOI] 10.3390/life11111127 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/life11111127 PMC 바로가기 [Article Type] Article
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Article
[키워드] Rhizopus
Antibiotics
cardiovascular disease
carried
Case series
caused
Characteristics
Co-infection
Comorbidities
Computed tomography
COVID-19
COVID-19 patients
critical COVID-19 patient
Critically ill
critically ill patients
Cross-infection
decreased mortality
Diabetes Mellitus
died
Effectiveness
Evidence
exhibited
facial
Factor
feature
FIVE
Follow-up
form
Fungal infection
hypertension
imperative
increased mortality
increasingly
Initially
Isolation
majority
males
management
medication
medications
Mortality
Mucorale
Mucorales
Mucormycosis
Mycoses
novel coronavirus disease
observational studies
outbreak
Patient
patients
PCR
polymerase chain
positive
potential risk
renal
reported
review
Rhizopus
risk
Risk factors
Seven
steroid
Steroids
surgical
tested
[DOI] 10.3390/jof7100837 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jof7100837 PMC 바로가기 [Article Type] Article
Clinical Treatment Experience in Severe and Critical COVID-19
Research Article
[키워드] age
Anti-inflammatory therapy
anticoagulant therapy
anticoagulation
carried
clinical
Comorbidity
coronavirus disease
COVID-19
Critical
Critical case
critical cases
critical COVID-19 patient
cured
cytokine
D-dimer
death
Diagnosis
died
Diseases
evaluate
experience
Factor
hospital
Hospitalization
hypersensitive C-reactive protein
Immunosuppression
infected cases
Inflammatory indicators
LDH
lymphocyte
Mortality
mortality rate
Occurrence
Older age
outcome
Patient
reduce
Retrospective study
Severe patient
significantly lower
suggested
thrombosis
time
treat
treated
Treatment
treatment effects
Wuhan, China
[DOI] 10.1155/2021/9924542 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/9924542 PMC 바로가기 [Article Type] Research Article
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
Medicine
[키워드] 28-day mortality
95% CI
Analysis
antibody
CBM
CCP
CNKI
conducted
control group
convalescent plasma
Corona
Coronavirus disease 2019
COVID-19
criteria
Critical
critical COVID-19 patient
Efficacy and safety
enrolled
Evidence
group
hospital
Hospital stay
ICU
ICU admission
incidence
Infection
Inflammatory
Intervention
mechanical ventilation
Meta-analysis
Mortality
mortality rate
no significant difference
novel
Novel coronavirus
overall mortality
participant
Patient
patients with COVID-19
PICOS
Placebo
placebo group
plasma
Primary outcome
Randomized controlled trial
RCT
RCTs
reduce
reducing
review
safety and efficacy
searched
secondary outcome
Serious Adverse Events
significant difference
significantly
significantly shorter
SSRN
subgroup analysis
subject
therapy
Treatment
treatment group
treatments of COVID-19
VIP
viral loads
Web of Science
worldwide pandemic
[DOI] 10.3389/fmed.2021.641429 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.641429 PMC 바로가기 [Article Type] Medicine
Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage
Medicine
[키워드] acute respiratory syndrome
addition
BALF
biochemical parameter
Blood
Bronchoalveolar lavage
Bronchoalveolar lavage fluid
Case report
Characteristics
characterization
clinical
Clinical characteristics
clinical trials
collected
Comorbidity
coronavirus
coronavirus disease
COVID-19
COVID-19 case
Critical
Critical case
critical COVID-19 patient
critical COVID-19 patients
Critically ill patient
cytokine
cytokine overproduction
death
demonstrated
diagnosed
enrolled
high risk
Hospitalization
hyperinflammation
Hyperinflammatory
IL-6
Ill
immunological
Infection
Inflammation
Intervention
laboratory result
lavage
liver
longitudinal
lung
Nasopharyngeal swab
outcome
outcomes
parameter
pathogen
Patient
poor outcomes
populations
positive
reduced
report
risk
RT-PCR
SARS-CoV-2
symptoms of COVID-19
T cell
tested
Therapies
therapy
Treatment
Two patient
was related
[DOI] 10.3389/fmed.2021.690523 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.690523 PMC 바로가기 [Article Type] Medicine